The primary aim of this study is to assess whether daily dosing of Medium Chain Triglycerides (MCT) oil will result in an improvement in cognitive performance in subjects with Mild Cognitive Impairment (MCI).
For questions and information about the following clinical trials, contact the IDRP at (225) 763-2973 or email dementia@pbrc.edu.
